Inhibitors of the RAAS, such as angiotensin converting enzyme inhibitors and angiotensin receptor blockers, are now emerged as novel drugs for the prevention and treatment of AF [4], [5], [6]. The gene discussed is ACE; the disease is atrial fibrillation.